Title: 2025-2026 Regular Session HB 377 PN 0333 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN0333
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HB 377 PN 0333 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 333 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.377 Session of 2025 INTRODUCED BY KUZMA, VENKAT, COOPER, SCIALABBA, JAMES, SCHEUREN, ZIMMERMAN, MARCELL, M. BROWN, KUTZ, HOGAN, MIHALEK, KAIL AND TOMLINSON, JANUARY 28, 2025 REFERRED TO COMMITTEE ON JUDICIARY, JANUARY 28, 2025 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for prohibited acts and penalties.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 13(a) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended by adding a clause and the section is amended by adding a subsection to read:Section 13. Prohibited Acts; Penalties.--(a) The following acts and the causing thereof within the Commonwealth are hereby prohibited:* * *(41) The manufacture, delivery or possession with intent to 12345678910111213141516171819202122 manufacture or deliver tianeptine or any salt, compound, derivative or preparation of tianeptine by a person not registered under this act or by a practitioner not registered or licensed by the appropriate State board.* * *(f.1) Any person who knowingly or intentionally violates clause (41) of subsection (a) is guilty of a felony and upon conviction thereof shall be sentenced to imprisonment not exceeding five years, or to pay a fine not exceeding fifteen thousand dollars ($15,000), or both.* * *Section 2. This act shall take effect immediately.20250HB0377PN0333 - 2 - 123456789101112


================================================================================

Raw Text:
2025-2026 Regular Session HB 377 PN 0333 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 333 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.377 Session of 2025 INTRODUCED BY KUZMA, VENKAT, COOPER, SCIALABBA, JAMES, SCHEUREN, ZIMMERMAN, MARCELL, M. BROWN, KUTZ, HOGAN, MIHALEK, KAIL AND TOMLINSON, JANUARY 28, 2025 REFERRED TO COMMITTEE ON JUDICIARY, JANUARY 28, 2025 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for prohibited acts and penalties.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 13(a) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended by adding a clause and the section is amended by adding a subsection to read:Section 13. Prohibited Acts; Penalties.--(a) The following acts and the causing thereof within the Commonwealth are hereby prohibited:* * *(41) The manufacture, delivery or possession with intent to 12345678910111213141516171819202122 manufacture or deliver tianeptine or any salt, compound, derivative or preparation of tianeptine by a person not registered under this act or by a practitioner not registered or licensed by the appropriate State board.* * *(f.1) Any person who knowingly or intentionally violates clause (41) of subsection (a) is guilty of a felony and upon conviction thereof shall be sentenced to imprisonment not exceeding five years, or to pay a fine not exceeding fifteen thousand dollars ($15,000), or both.* * *Section 2. This act shall take effect immediately.20250HB0377PN0333 - 2 - 123456789101112